Extrapyramidal symptoms are a complication of treatment with following drugs:
**Question:** Extrapyramidal symptoms are a complication of treatment with following drugs:
A. Antipsychotics
B. Antiepileptics
C. Antidepressants
D. Antimalarials
**Core Concept:**
Extrapyramidal symptoms (EPS) are a group of motor disturbances characterized by abnormal involuntary movements (e.g., tremors, rigidity, and dystonia). They result from the blockade of dopaminergic neurotransmission in the basal ganglia and are associated with certain medications.
**Why the Correct Answer is Right:**
Extrapyramidal symptoms are primarily caused by the drugs that affect dopaminergic neurotransmission in the basal ganglia. In this case, the correct answer (A) is due to the fact that antipsychotics are known to antagonize dopamine D2 receptors, leading to the disruption of normal motor control and the development of EPS.
**Why Each Wrong Option is Incorrect:**
A. Antiepileptics (B): Although some antiepileptic drugs (AEDs) can cause EPS, this is less common compared to antipsychotics. AEDs primarily affect other neurotransmitter systems, e.g., GABA, glutamate, and gamma-aminobutyric acid (GABA).
B. Antidepressants (C): Antidepressants primarily affect serotonin, norepinephrine, and, to a lesser extent, dopamine neurotransmission. Although some tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) can cause EPS, this is less common compared to antipsychotics.
C. Antimalarials (D): Antimalarials primarily affect the immune response and parasitic infections, and have little to no direct effect on dopaminergic neurotransmission. The development of EPS is less likely with antimalarials compared to antipsychotics.
**Clinical Pearl:**
When prescribing antipsychotics, it is crucial to monitor patients for the development of EPS, as they may lead to adverse effects on the patient's quality of life and increase the risk of falls and fractures. Early recognition and management can prevent complications and improve patient outcomes.